About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 204 record(s)
Req # A-2021-07885
Copies of all briefing notes provided to the Deputy Minister regarding the implementation of the new PMPRB guidelines on July 1, 2021 from January 1, 2021 to April 28, 2021.Organization: Patented Medicine Prices Review Board Canada
May 2021
Req # A-2021-07888
Copies of all briefing notes provided to the Deputy Minister regarding the possible delay in the implementation of the new PMPRB guidelines from January 1, 2021 to April 28, 2021.Organization: Patented Medicine Prices Review Board Canada
May 2021
Req # A-2021-07890
Copies of all emails sent/received from Douglas Clark, Tanya Potashnik, Mitchell Levine and Isabel Jaen Raasch discussing the possible delaying in the implementation of the new PMPRB guidelines from January 1, 2021 to April 28, 2021.Organization: Patented Medicine Prices Review Board Canada
May 2021
Req # A-2021-07891
Copies of all emails and meeting summaries regarding the PMPRB's consultation with IMC about the new PMPRB guidelines.Organization: Patented Medicine Prices Review Board Canada
May 2021
Req # A-2021-07893
Copies of emails, HR work plans, and other documents among PMPRB executives regarding the increase in hiring of PMPRB employees from June 1, 2019 to April 28, 2021.Organization: Patented Medicine Prices Review Board Canada
May 2021
Req # A-2021-09406
Copies of emails to/from/cc'ing Douglas Clark, Tanya Potashnik and Mitchell Levine on negative feedback from groups consulted over the new PMPRB guidelines from June 1, 2019 to December 31, 2020.Organization: Patented Medicine Prices Review Board Canada
May 2021
Req # A-2021-09407
Copies of emails to/from/cc'ing Douglas Clark, Tanya Potashnik and Mitchell Levine on negative feedback from the public over the new PMPRB guidelines from June 1, 2019 to December 31, 2020.Organization: Patented Medicine Prices Review Board Canada
May 2021
Req # A-2020-03991
Copies of all records, analysis, correspondence, discussions, briefings, memos and decisions, about the development of the PMPRB regulations involving individuals with a classification of AS-04 and above, PM-04 and above, EC-04 and above, and EX-all levels. Also include the Minister and Political staff; between January 2016 to February 2020.Organization: Patented Medicine Prices Review Board Canada
April 2021
Req # A-2020-03992
Copies of all analysis, correspondence, discussions, briefings and memos about the evaluation of stakeholder submissions for the PMPRB regulations (including submissions relating to the 2016 PMPRB guidelines modernization, the 2017 consultations on potential changes to the PMPRB regulations, Canada Gazette Part I, and Canada Gazette Part II) involving individuals with a classification of AS-04 and above, PM-04 and above, EC-04 and above, EX-all levels. Include the Minister and Political staff; between January 2016 to February 2020.Organization: Patented Medicine Prices Review Board Canada
April 2021
Req # A-2021-05507
Copies of all communications to/from Douglas Clark regarding the timelines of CADTH and pCPA's drug review process from June 1, 2019 to March 3, 2021.Organization: Patented Medicine Prices Review Board Canada
April 2021